Received Sep 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | UNK | — | OT |
The virus reactivated; This initial spontaneous safety report was reported by a Consumer or other non-health professional and concerns an individual of unspecified age and gender who experienced the virus reactivated on an unspecified date after receiving COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) on an unspecified date. At the time of the report, the outcome of the Viral infection was Unknown. On 29-Aug-2025, significant information was received from consumer via contact center (MI No. NOV25-00697): The following Reporter updates were made: The primary reporter's city was updated. The postal code was updated The following patient demographics were updated: The patient's gender was updated to female.; Sender's Comments: This Female of an unspecified age experienced Viral infection after vaccination with COVID-19 Vaccine, Adjuvanted (2023-2024 Formula). The event Viral infection was reported as non-serious. Based on the spontaneous nature of the report, the causal relationship between COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) and Viral infection is considered Possible.